Albany, NY -- (SBWIRE) -- 12/24/2014 -- Breast cancer is one of the most common forms of cancer which is frequently diagnosed in women above 40 years of age. This cancer is readily diagnosed in aged women and is one of the leading causes of death among them. At present, hormone refractory breast cancers are occurring increasingly due to rising number of hormone therapies that have made breast cancers resistant to most of these therapies, hence are also referred to as hormone-resistant breast cancers. However, various drug developers are increasingly conducting clinical trials to test the effectiveness of the chemotherapeutic agents other than hormones that can be helpful in treating such hormone-resistant breast cancers. Some of the chemotherapeutic agents, such as, trastuzumab and everolimus alone and/or trastuzumab and everolimus in combination are under clinical trials for effective management of hormone refractory breast cancers.

Early buyers will receive 10% customization on reports :
http://www.transparencymarketresearch.com/hormone-refractory-breast-cancer-market.html

Key factors driving the growth of this market include, increasing incidences of breast cancers, rising prevalence of hormone refractory breast cancers, aging population, rising demand for advanced therapeutics and presence of large number of pipeline drugs in this market. According to world health organization (WHO) estimates, cancer is the most potent killer, which killed more than 8.2 million people worldwide in 2012. Among them, breast cancer, which is the most potent killer among women that killed around 521,000 people globally in 2012. Presently, many of the breast cancer patients have developed hormone-resistant breast cancer due to elevated usage hormone therapy in most parts of the world, especially in the developed parts of the world. According to Centers for Disease Control and Prevention (CDC), 220,097 women and 2,078 men were diagnosed with breast cancer and among them 40,931 women and 443 men died in the U.S. in 2011. High geriatric population in developed nations is also increasingly contributing towards increasing number of breast cancer patients globally as aged women tend to suffer more from breast cancer and other forms of it. High demand for advanced treatment options for effective management and to increase the lifespan of the cancer patients will also add to the growth of this market. A large number of molecules in different stages of clinical trials that will soon be commercialized in the global market will augment the growth of this market in future.

Geographically, North America holds the leading position in breast cancer treatment and diagnostics market followed by Europe. Thus, it is expected that these regions will dominate the hormone refractory breast cancer market in future. Some of the key factors responsible for their expected dominance in this market are presence of large number of patients with hormone refractory breast cancers along with high geriatric population in these regions. A considerable amount of research and development in the field of hormone refractory breast cancer in the region by several drug developers in the region will add to the growth of this market in the region.

However, Asia Pacific region is expected to show a rapid growth in future due to rapidly increasing healthcare infrastructure and improving purchasing power of the population in the region. Presence of the most rapidly emerging economies of the world, such as, China and India along with growing medical tourism in the region will add to their growth in this market in future. Some of the key players having their drugs in different stages of clinical trials include, AmpliMed Corporation, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim GmbH, Bluefish Pharmaceuticals AB, Bioenvision Limited, NeoCorp GmbH and Neopharm Ltd.

More Reports on Pharmaceutical Market :
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:

- North America
- Asia Pacific
- Europe
- Rest of the World

This report provides comprehensive analysis of:

- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter's five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Enquiry Before Buying :
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3355

About Transparency Market Research
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: 518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse Market Research Blog:
http://pharmaceuticalresearchreport.blogspot.com/